On May 19, 2026, Aimei Health Technology Co. received formal notification from Nasdaq for failing to file its Form 10-Q by the May 15 deadline for the quarter ended March 31, 2026, breaching Listing Rule 5250(c)(1). The notice does not immediately affect trading but flags a deficiency in listing qualifications.

Under Nasdaq rules, the company has 60 calendar days to either file the delayed report or submit a remedial plan. If the plan is accepted, Aimei may be granted up to 180 days from the original due date to regain compliance; otherwise, its securities could be subject to delisting, though an appeal to a hearings panel is available.